Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients.

Marre M, Van Gaal L, Usadel KH, Ball M, Whatmough I, Guitard C.

Diabetes Obes Metab. 2002 May;4(3):177-86.

PMID:
12047396
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.

Campbell IW.

Int J Clin Pract. 2005 Oct;59(10):1218-28. Review.

PMID:
16178991
4.

Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.

Rosenstock J, Fitchet M.

Int J Clin Pract Suppl. 2008 Mar;(159):15-23. doi: 10.1111/j.1742-1241.2007.01692.x. Review.

PMID:
18269437
5.

Nateglinide (Starlix): update on a new antidiabetic agent.

Phillips LS, Dunning BE.

Int J Clin Pract. 2003 Jul-Aug;57(6):535-41. Review.

PMID:
12918894
6.

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes.

Israel MK, Istvan E, Baron MA.

Vasc Health Risk Manag. 2008;4(6):1167-78. Review.

7.

Nateglinide.

Dunn CJ, Faulds D.

Drugs. 2000 Sep;60(3):607-615; discussion 616-7. Review.

PMID:
11030470
8.

Restoring post-prandial insulin release in type 2 diabetes.

Andrews J.

Hosp Med. 2002 Feb;63(2):95-8. Review.

PMID:
11902096
9.

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.

Nauck M, Frid A, Hermansen K, Thomsen AB, During M, Shah N, Tankova T, Mitha I, Matthews DR.

Diabetes Obes Metab. 2013 Mar;15(3):204-12. doi: 10.1111/dom.12012. Epub 2012 Oct 11. Review.

PMID:
22985213
10.

Meglitinide analogues for type 2 diabetes mellitus.

Black C, Donnelly P, McIntyre L, Royle PL, Shepherd JP, Thomas S.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004654. Review.

PMID:
17443551
11.

Nateglinide: a new rapid-acting insulinotropic agent.

Hanif W, Kumar S.

Expert Opin Pharmacother. 2001 Jun;2(6):1027-31. Review.

PMID:
11585005
12.

A review of nateglinide in the management of patients with type 2 diabetes.

Tentolouris N, Voulgari C, Katsilambros N.

Vasc Health Risk Manag. 2007;3(6):797-807. Review.

13.

Nateglinide.

Halas CJ.

Am J Health Syst Pharm. 2001 Jul 1;58(13):1200-5. Review.

PMID:
11449877
14.

Meglitinide analogues in the treatment of type 2 diabetes mellitus.

Landgraf R.

Drugs Aging. 2000 Nov;17(5):411-25. Review.

PMID:
11190420
15.

The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Singh-Franco D, McLaughlin-Middlekauff J, Elrod S, Harrington C.

Diabetes Obes Metab. 2012 Aug;14(8):694-708. doi: 10.1111/j.1463-1326.2012.01586.x. Epub 2012 Mar 20. Review.

PMID:
22340363
16.

[Nateglinide].

Notoya Y, Kikuchi M.

Nihon Rinsho. 2002 Sep;60 Suppl 9:371-5. Review. Japanese. No abstract available.

PMID:
12387020
17.

Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.

Pratley RE, Foley JE, Dunning BE.

Curr Pharm Des. 2001 Sep;7(14):1375-97. Review.

PMID:
11472274
18.

Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.

Liu SC, Tu YK, Chien MN, Chien KL.

Diabetes Obes Metab. 2012 Sep;14(9):810-20. doi: 10.1111/j.1463-1326.2012.01606.x. Epub 2012 Apr 29. Review.

PMID:
22486990
19.

Nateglinide therapy for type 2 diabetes mellitus.

Levien TL, Baker DE, Campbell RK, White JR Jr.

Ann Pharmacother. 2001 Nov;35(11):1426-34. Review.

PMID:
11724096
20.

Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus.

F├╝chtenbusch M, Standl E, Schatz H.

Exp Clin Endocrinol Diabetes. 2000;108(3):151-63. Review.

PMID:
10926309
Items per page

Supplemental Content

Write to the Help Desk